Targeting cancer-associated fibroblasts (CAFs) toward reduction of tumor immune suppression capacity in triple negative breast cancer.
Project Member(s): Ebrahimi Warkiani, M.
Funding or Partner Organisation: University of Sydney (Sydney Vital - Northern Clinical School)
University of Sydney (Sydney Vital - Northern Clinical School)
Start year: 2019
FOR Codes: Cancer and Related Disorders, Cancer Cell Biology, Clinical health